SCHEDULE: Avoro Capital Discloses 6.72% Stake in Celcuity Inc.

Avoro Capital Advisors LLC and Behzad Aghazadeh have reported a beneficial ownership of 6.72% in Celcuity Inc., holding 3,111,111 shares for investment purposes.

Summary

• Avoro Capital Advisors LLC and Behzad Aghazadeh (collectively, the "Reporting Persons") have filed a Schedule 13G, disclosing their beneficial ownership in Celcuity Inc.
• The Reporting Persons collectively own 3,111,111 shares of Celcuity Inc. Common Stock.
• This ownership represents 6.72% of Celcuity Inc.'s outstanding Common Stock.
• The percentage is calculated based on 46,271,259 shares outstanding as of November 6, 2025, as reported in Celcuity Inc.'s Form 10-Q for the quarter ended September 30, 2025.
• The shares were acquired solely for investment purposes and not with the intent to change or influence control of the issuer.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, as a significant stake by a specialized investment firm like Avoro Capital Advisors can be interpreted as a vote of confidence in Celcuity Inc.'s future, even if it's a passive investment.

Positives

• A significant institutional investor, Avoro Capital Advisors LLC, and its controlling person, Behzad Aghazadeh, have taken a substantial 6.72% stake in Celcuity Inc.
• The acquisition is stated to be for investment purposes, suggesting confidence in the company's long-term prospects without immediate intent to influence control.

Negatives

• NA

Risks

• NA

Future Outlook

NA (This filing does not provide forward-looking statements or guidance from the issuer.)

Management Comments

• The securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §§ 240.14a-11.

Industry Context

StockSavvy.ai notes that a significant stake by an investment advisor like Avoro Capital Advisors, specializing in life sciences, often signals a positive long-term view on the company's prospects within its sector. This type of disclosure can attract further investor attention to Celcuity Inc., particularly from those who track institutional movements in the biotechnology and healthcare investment space.

Comparison to Industry Standards

• NA (This filing, a Schedule 13G, primarily discloses beneficial ownership and does not contain performance data or operational results that would allow for a direct comparison to industry standards or specific comparable companies/projects.)

Stakeholder Impact

• Shareholders: Existing shareholders may view this as a positive signal, potentially increasing confidence and attracting new investors.
• Management: Management may see this as validation of their strategy, though the filing explicitly states no intent to influence control.
• Potential Investors: The disclosure could draw attention from other institutional investors and analysts, leading to increased scrutiny and potentially higher trading volume.

Key Dates

Recommendation

While the disclosure of a significant stake by a reputable investment firm is generally positive, a Schedule 13G filing primarily indicates passive investment intent. It does not provide new operational or financial performance data to warrant an immediate 'buy' recommendation. Investors should 'hold' and monitor future developments, including Celcuity Inc.'s operational performance and any further actions by Avoro Capital Advisors, to assess the long-term implications of this ownership.

Keywords

Celcuity Inc., Avoro Capital Advisors, Behzad Aghazadeh, Schedule 13G, Beneficial Ownership, Institutional Investment, Common Stock, Biotechnology, Healthcare Investment